secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartBeam, Inc. (BEAT)
CIK:        0001779372
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001779372-23-000009
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartBeam closes $25M secondary offering; shifts commercial launch to 2024
--------------------------------------------------------------------------

- Offering of 16.67M shares at $1.50/share closed on May 2, 2023; net proceeds $23.2M.
- No material commercial revenue expected in 2023; cash runway extended into late 2024.
- Company to focus on FDA 510(k) clearance for HeartBeam AIMIGo 12-lead equivalence; submission planned late 2023.
- Strategic shift to delay commercial launch until after 12-lead equivalence clearance, targeting 2024.
- Placement agent Public Ventures received warrants for 1.67M shares; $10M of proceeds earmarked for FDA work and limited market releases.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779372/000177937223000009/0001779372-23-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779372/000177937223000009/beat-20230502.htm
  HTML page:      https://secwatch.observer/filing/0001779372-23-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer